These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15300227)
1. Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis. Yamanaka S; Sunamura M; Furukawa T; Sun L; Lefter LP; Abe T; Yatsuoka T; Fujimura H; Shibuya E; Kotobuki N; Oshimura M; Sakurada A; Sato M; Kondo T; Matsuno S; Horii A Lab Invest; 2004 Oct; 84(10):1339-51. PubMed ID: 15300227 [TBL] [Abstract][Full Text] [Related]
2. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines. Lefter LP; Furukawa T; Sunamura M; Duda DG; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557 [TBL] [Abstract][Full Text] [Related]
3. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma. Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of chromosome 18 in pancreatic cancer: strong evidence for new tumour suppressor genes. Lefter LP; Sunamura M; Furukawa T; Yastsuoka T; Abe H; Inoue H; Abe T; Egawa S; Miura K; Morita R; Horii A; Matsuno S Asian J Surg; 2004 Apr; 27(2):85-92. PubMed ID: 15140658 [TBL] [Abstract][Full Text] [Related]
5. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype. Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380 [TBL] [Abstract][Full Text] [Related]
6. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198 [TBL] [Abstract][Full Text] [Related]
7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related]
9. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts. Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7. Zenklusen JC; Oshimura M; Barrett JC; Conti CJ Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587 [TBL] [Abstract][Full Text] [Related]
11. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028 [TBL] [Abstract][Full Text] [Related]
12. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
13. Mast cells and angiogenesis in pancreatic ductal adenocarcinoma. Longo V; Tamma R; Brunetti O; Pisconti S; Argentiero A; Silvestris N; Ribatti D Clin Exp Med; 2018 Aug; 18(3):319-323. PubMed ID: 29492715 [TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features. Zhao L; Cui Q; Lu Z; Chen J Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082 [TBL] [Abstract][Full Text] [Related]
16. The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer. Ishida M; Sunamura M; Furukawa T; Lefter LP; Morita R; Akada M; Egawa S; Unno M; Horii A Dig Dis Sci; 2008 Sep; 53(9):2576-82. PubMed ID: 18231856 [TBL] [Abstract][Full Text] [Related]
17. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells. Li J; Belogortseva N; Porter D; Park M Cell Cycle; 2008 Sep; 7(18):2886-93. PubMed ID: 18787405 [TBL] [Abstract][Full Text] [Related]
18. KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Zammarchi F; Morelli M; Menicagli M; Di Cristofano C; Zavaglia K; Paolucci A; Campani D; Aretini P; Boggi U; Mosca F; Cavazzana A; Cartegni L; Bevilacqua G; Mazzanti CM Am J Pathol; 2011 Jan; 178(1):361-72. PubMed ID: 21224073 [TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2. Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883 [TBL] [Abstract][Full Text] [Related]
20. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]